New: NCI-funded clinical trial search
Mednet Logo
CommunityNeurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you approach treatment of a glioblastoma in pregnancy?

2
3 Answers

Mednet MemberInvited Expert
Radiation Oncology · University of Louisville School of Medicine

Glioblastoma during pregnancy could be treated safely (to mother and fetus) with certain precautions and modifications. Collaboration and consultation with the patient’s obstetrician are essential. External shielding over the patient’s abdomen during treatment will decrease the external scatter radi...

What is your management approach to a patient who develops a CVST while on a DOAC?

1 Answers

Mednet MemberInvited Expert
Neurology · University of Arizona College of Medicine - Tucson

This is an excellent question. First and foremost, it is important to understand the underlying etiology of cerebral venous sinus thrombosis (CVST) occurring despite ongoing direct oral anticoagulant (DOAC) therapy. For instance, is the event driven by an acquired prothrombotic condition, such as ma...

Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?

2
2 Answers

Mednet MemberInvited Expert
Infectious Disease · University of Washington Center for AIDS and STD

Syphilis is a rare cause of dementia without other evidence of neurological disease, at least in the US and most other industrialized countries. Of course, a careful neurological examination is required for all dementia patients, but the absence of other manifestations of neurosyphilis makes testing...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

For stroke patients with ablated paroxysmal atrial fibrillation without known recurrence and ICAD, would you recommend dual antiplatelet therapy or anticoagulation with or without an antiplatelet agent?

1
4 Answers

Mednet Member
Neurology · University of Colorado, Climate & Health Dept

Ablation treats cardiopulmonary symptoms, but it has not been adequately tested against anticoagulation for AFib-related stroke. Anecdotally, at least once a month, I will see a patient with an acute embolic-appearing stroke after their cardiologist has stopped their anticoagulation because they wer...

In a young patient with recurrent low-grade glioma s/p gross total resection, is there any role for further observation instead of radiation and chemotherapy?

4
6 Answers

Mednet MemberInvited Expert
Radiation Oncology · Florida International University

As simple as this question seems to be on the surface, it is actually a very difficult clinical scenario to opine with certainty, primarily because of a lack of data. So, let us address this with each option in mind, weighing the pros and cons: Observation: We do know that in resected patients, radi...

In older adults with mild cognitive impairment, do you ever prescribe cholinesterase inhibitors and/or memantine?

4
5 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Wake Forest University School of Medicine

This is a great question, and of course, "do you ever" will get you in trouble every time! Let me start by saying that, in general, I do not prescribe these drugs for MCI. Cholinesterase inhibitors are clearly indicated for the mild-moderate stage of some kinds of dementia (some people would include...

How do you approach timing of repeat plasma p-tau217/Aβ42 monitoring to detect conversion in MCI due to suspected Alzheimer’s disease?

1 Answers

Mednet MemberInvited Expert
Neurology · University of Minnesota

I think that this question is purely “academic” and not relevant for clinical practice. If a patient has clear evidence of MCI based on history and bedside cognitive testing results, and ptau217/Αβ42 ratio falls within the intermediate/non-diagnostic range, then the appropriate course of action, if ...

When would you repeat antibody testing for seronegative myasthenia gravis?

2 Answers

Mednet MemberInvited Expert
Neurology · University of Minnesota

I will usually recheck in 1-2 years, but I mostly focus on acetylcholine receptor antibodies. I have never seen seroconversion from MuSK negative to MuSK positive. Also, if initial antibody testing for Acetylcholine receptor binding/modulating and MuSK antibodies is negative by RIA assay, I recommen...

What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?

3
4 Answers

Mednet MemberInvited Expert
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

I have a shared decision-making discussion with the patient, especially alluding to the fact that the result would not change my therapy (i.e., use neuropathic analgesics for treatment) for small fiber neuropathy (SFN). Where I find it especially useful is in a patient with systemic lupus (SLE) or S...

What is your preferred first-line agent to treat anxiety in patients with Parkinson's disease?

5
3 Answers

Mednet MemberInvited Expert
Neurology · University of Miami Miller School of Medicine

Any standard SSRI/SNRI can be tried. I like to try the SNRIs duloxetine or venlafaxine. If comorbid insomnia is a problem, mirtazapine may be a good choice. Think about talk therapy too. It is important to make sure episodic anxiety is not a non-motor symptom fluctuation related to levodopa or oth...